Remote Symptom Review in Patients With Implantable Diagnostic Holter
NCT06431828
Summary
To study the clinical and organizational benefit of implementing a methodology for monitoring patients receiving an implantable diagnostic BIOMONITOR III holter and successive models, consisting of remote review of alerts sent by the device via the HOME MONITORING remote monitoring platform and the transmission of relevant patient symptoms through the use of a specific application installable on the patient's phone. The efficiency of this methodology will be compared with a control group consisting of monitoring through the usual clinical practice of the hospital.
Eligibility
Inclusion Criteria: * Patients indicated for implantation of a subcutaneous implantable holter due to syncope or cryptogenic stroke (atrial fibrillation detection) * Patients over 18 years old. * Patients who consent to the installation of a patient application for telematic submission of patient-related symptoms. * Patients capable of using the patient application. Exclusion Criteria: * Patients over 80 years of age or, failing that, not able to use an application to send their symptoms. * Life expectancy of less than 12 months for any reason.
Conditions5
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT06431828